English | Español
Patient Daily | Nov 9, 2025

UTHealth Houston receives Top Workplace honor from Houston Chronicle for 11th time

Trending
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Novavax shareholder plans to oppose CEO pay and board at upcoming meeting
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Kailera Therapeutics announces potential $533 million IPO in obesity drug market
+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’